FinancialContent

Articles published by Medexus Pharmaceuticals Inc

News headline image
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Announces New License Deal for Topical Terbinafine
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Announces US$58.5 million in New Credit Facilities
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus to Participate in 35th Annual Roth Conference
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Welcomes Two New Board Members
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Schedules Second Quarter 2023 Conference Call
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP
News headline image
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Tickers MEDXF TSX:MDP